Amy Feldman

Forus reached $1 billion valuation by dealing with the unglamorous admin work of processing scrips so patients can get the drugs they need. N

NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.

In this week's edition of InnovationRx, we look at the latest on the hantavirus outbreak, using quantum physics for metabolic MRIs, how AI can help fill prescriptions and more. To get it in your inbox, subscribe here

Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it's tight-lipped on what drugs it might bring to the clinic.

In this week's edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure's $7 billion valuation, and more.

In this week's edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure's $7 billion valuation, and more.

In this week's edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly's trio of vaccine deals, and more.

In this week's edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly's trio of vaccine deals, and more.

In this week's edition of InnovationRx, we look at cancer breakthroughs from the ASCO conference, Clear's move into healthcare, Harrison.ai's U.S. expansion, and more.

Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it's in talks to raise $400 million more VC funding at a $3.4 billion valuation, Forbes has learned.